Recombinant α1-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a 177Lu-DOTATATE Mouse Radiation Model
Biomolecules · 2023
DOI: 10.3390/biom13060928 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Abdul Ghani Alattar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, 221 84 Lund, Sweden. Hauptthemen laut MEDLINE: Octreotide, Organometallic Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Crafoordska Foundation, Berta Kamprad Foundation, Alfred Österlunds Foundation.
Abstract (Originalsprache)
177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) is used clinically to treat metastasized or unresectable neuroendocrine tumors (NETs). Although 177Lu-DOTATATE is mostly well tolerated in patients, bone marrow suppression and long-term renal toxicity are still side effects that should be considered. Amino acids are often used to minimize renal radiotoxicity, however, they are associated with nausea and vomiting in patients. α1-microglobulin (A1M) is an antioxidant with heme- and radical-scavenging abilities. A recombinant form (rA1M) has previously been shown to be renoprotective in preclinical models, including in PRRT-induced kidney damage. Here, we further investigated rA1M’s renal protective effect in a mouse 177Lu-DOTATATE model in terms of administration route and dosing regimen and as a combined therapy with amino acids (Vamin). Moreover, we investigated the protective effect of rA1M on peripheral blood and bone marrow cells, as well as circulatory biomarkers. Intravenous (i.v.) administration of rA1M reduced albuminuria levels and circulatory levels of the oxidative stress-related protein fibroblast growth factor-21 (FGF-21). Dual injections of rA1M (i.e., at 0 and 24 h post-177Lu-DOTATATE administration) preserved bone marrow cellularity and peripheral blood reticulocytes. Administration of Vamin, alone or in combination with rA1M, did not show any protection of bone marrow cellularity or peripheral reticulocytes. In conclusion, this study suggests that rA1M, administered i.v. for two consecutive days in conjunction with 177Lu-DOTATATE, may reduce hematopoietic and kidney toxicity during PRRT with 177Lu-DOTATATE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, 221 84 Lund, Sweden.
- Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, 221 84 Lund, Sweden.
- Pediatrics, Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, 221 84 Lund, Sweden.
- Department of Clinical Sciences Lund, CIPA, Lund University, 221 84 Lund, Sweden.
- Department of Medical Radiation Sciences, Sahlgrenska Cancer Center, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 413 45 Gothenburg, Sweden.
- Department of Clinical Sciences Lund, Section for Infection Medicine, Lund University, 221 84 Lund, Sweden.
ORCID-Profile: Abdul Ghani Alattar, Amanda Kristiansson, Eva Forssell-Aronsson, Sven-Erik Strand, Johan Flygare, Magnus Gram
Förderung
- Crafoordska Foundation
- Berta Kamprad Foundation
- Alfred Österlunds Foundation
- Greta and Johan Kock Foundation
- Swedish research Council
- Swedish Cancer Society
- Guard Therapeutics International
Zitieren
APA
Alattar, A. G., Kristiansson, A., Karlsson, H., Vallius, S., Ahlstedt, J., Forssell-Aronsson, E., Åkerström, B., Strand, S. E., Flygare, J., & Gram, M. (2023). Recombinant α1-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a 177Lu-DOTATATE Mouse Radiation Model. Biomolecules. https://doi.org/10.3390/biom13060928
Vancouver
Alattar AG, Kristiansson A, Karlsson H, Vallius S, Ahlstedt J, Forssell-Aronsson E, et al. Recombinant α1-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a 177Lu-DOTATATE Mouse Radiation Model. Biomolecules. 2023. doi:10.3390/biom13060928
BibTeX
@article{Alattar2023,
author = {Alattar, Abdul Ghani and Kristiansson, Amanda and Karlsson, Helena and Vallius, Suvi and Ahlstedt, Jonas and Forssell-Aronsson, Eva and Åkerström, Bo and Strand, Sven-Erik and Flygare, Johan and Gram, Magnus},
title = {Recombinant α1-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a 177Lu-DOTATATE Mouse Radiation Model},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13060928}
}
EUVIMED